Follow
paola indovina
paola indovina
Unknown affiliation
Verified email at inwind.it
Title
Cited by
Cited by
Year
Virtual Reality as a Distraction Intervention to Relieve Pain and Distress During Medical Procedures: A Comprehensive Literature Review
P Indovina, D Barone, L Gallo, A Chirico, G De Pietro, G Antonio
The Clinical Journal of Pain, 2018
3672018
Virtual reality and music therapy as distraction interventions to alleviate anxiety and improve mood states in breast cancer patients during chemotherapy
A Chirico, P Maiorano, P Indovina, C Milanese, GG Giordano, F Alivernini, ...
Journal of cellular physiology 235 (6), 5353-5362, 2020
2272020
Emerging roles of RB family: new defense mechanisms against tumor progression
P Indovina, E Marcelli, N Casini, V Rizzo, A Giordano
Journal of cellular physiology 228 (3), 525-535, 2013
1912013
RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy
P Indovina, F Pentimalli, N Casini, I Vocca, A Giordano
Oncotarget 6 (20), 17873, 2015
1782015
Mass spectrometry‐based proteomics: The road to lung cancer biomarker discovery
P Indovina, E Marcelli, F Pentimalli, P Tanganelli, G Tarro, A Giordano
Mass spectrometry reviews 32 (2), 129-142, 2013
1072013
Extremely low frequency (ELF) magnetic fields and apoptosis: a review
MT Santini, A Ferrante, G Rainaldi, P Indovina, PL Indovina
International Journal of Radiation Biology 81 (1), 1-11, 2005
952005
Expression of neuronal markers during NTera2/cloneD1 differentiation by cell aggregation method
F Megiorni, B Mora, P Indovina, MC Mazzilli
Neuroscience letters 373 (2), 105-109, 2005
732005
Metabolomics Using 1H-NMR of Apoptosis and Necrosis in HL60 Leukemia Cells: Differences between the Two Types of Cell Death and Independence from the …
G Rainaldi, R Romano, P Indovina, A Ferrante, A Motta, PL Indovina, ...
Radiation research 169 (2), 170-180, 2008
712008
Lung cancer proteomics: recent advances in biomarker discovery
P Indovina, E Marcelli, P Maranta, G Tarro
International journal of proteomics 2011 (1), 726869, 2011
692011
CTLA-4+ 49 A/G dimorphism in Italian patients with celiac disease
B Mora, M Bonamico, P Indovina, F Megiorni, M Ferri, MC Carbone, ...
Human immunology 64 (2), 297-301, 2003
572003
Downregulation and aberrant promoter methylation of p16INK4A: A possible novel heritable susceptibility marker to retinoblastoma
P Indovina, A Acquaviva, G De Falco, V Rizzo, A Onnis, A Luzzi, F Giorgi, ...
Journal of Cellular Physiology 223 (1), 143-150, 2010
552010
The Oncolytic Virus dl922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth
S Di Somma, CA Iannuzzi, C Passaro, IM Forte, R Iannone, V Gigantino, ...
Frontiers in oncology 9, 564, 2019
532019
Antitumoral potential, antioxidant activity and carotenoid content of two Southern Italy tomato cultivars extracts: San Marzano and Corbarino
D Barone, L Cito, G Tommonaro, AA Abate, D Penon, R De Prisco, ...
Journal of cellular physiology 233 (2), 1266-1277, 2018
502018
New pyrazolo [3, 4-d] pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization
P Indovina, F Giorgi, V Rizzo, B Khadang, S Schenone, D Di Marzo, ...
Oncogene 31 (7), 929-938, 2012
502012
Anticancer therapeutic strategies based on CDK inhibitors.
L Esposito, P Indovina, F Magnotti, D Conti, A Giordano
Current pharmaceutical design, 2013
452013
Hypoxia increases adhesion and spreading of MG-63 three-dimensional tumor spheroids
P Indovina, G Rainaldi, MT Santini
Anticancer research 28 (2A), 1013-1022, 2008
432008
Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma.
PF Di Marzo D, Forte IM, Indovina P, Di Gennaro E
Cell Cycle. 13 (4), 652-65, 2014
422014
Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide
IM Forte, P Indovina, CA Iannuzzi, D Cirillo, D Di Marzo, D Barone, ...
International journal of oncology 54 (6), 2189-2199, 2019
392019
NONO regulates the intra-S-phase checkpoint in response to UV radiation
L Alfano, C Costa, A Caporaso, A Altieri, P Indovina, M Macaluso, ...
Oncogene 35 (5), 567-576, 2016
362016
Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition
M Cozzi, F Giorgi, E Marcelli, F Pentimalli, IM Forte, S Schenone, ...
Cell Cycle 11 (5), 1029-1039, 2012
352012
The system can't perform the operation now. Try again later.
Articles 1–20